Board approved audited standalone and consolidated financial results for Q4 and FY26 ended March 31, 2026.
Recommended final dividend of ₹5 per share, bringing total FY26 dividend to ₹10 per share with record date August 28, 2026.
Reappointed Dr. Udayant Malhoutra as CEO & MD for 5 years and noted resignation of director Mr. Dietmar Hahn.
Auditors issued unmodified opinion on annual results with exceptional items from labour codes and UK restructuring.